Indetexx Deepens Commitment to South American Market: Enhancing Operational Support for Second-Hand Goods Importers

|

Indetexx, a trusted exporter of second-hand goods to over 110 countries, is strengthening its commitment to South American markets by enhancing operational support for import partners in Chile, Peru, and Colombia. As demand for affordable second-hand goods continues to rise, the company is taking strategic steps to help its partners navigate a landscape shaped by… Read more »

Cascade Custom Construction Launches C3 Groundworks to Expand Turnkey Excavation, Site Development and Foundation Services in Idaho

|

Cascade Custom Construction, a Southern Idaho builder known for custom barndominiums, pole barns, shops and stick-framed homes, today announced the launch of C3 Groundworks, a sister company created to bring excavation, site development and foundational site services into the Cascade family of companies. Serving Boise, the Treasure Valley and surrounding Southern Idaho communities, C3 Groundworks… Read more »

HailBytes Launches Phishing Simulation Platform on AWS and Azure to Help Companies Cut Human Error

|

With 68% of breaches still involving a non-malicious human element (Verizon DBIR 2024), HailBytes SAT – a self-hosted enterprise phishing-simulation and training platform with recurring campaigns, interactive quizzes, and auto-generated branded certificates of completion – is now available on AWS Marketplace and Azure Marketplace with hourly pricing, unlimited campaigns for unlimited users, and a 30-day free trial.

‘Biohackers Found a New Plateau Obsession’: California Trim Clinic Breaks Down SLU-PP-332 + BAM-15, the Experimental Stack Raising Eyebrows

|

Biohacker spaces have found a new plateau obsession, and this one is drawing sharper questions than usual. SLU-PP-332 and BAM-15 are being discussed online as a gray-market “metabolic accelerator” stack for patients frustrated by stalled fat loss, especially after Tirzepatide plateaus. California Trim Clinic says the patient concern is real, but the evidence line is clear: Tirzepatide has human obesity and plateau data, while SLU-PP-332 and BAM-15 remain experimental compounds supported mainly by preclinical research. The clinic is stepping into the conversation as the calm authority separating online hype from physician-guided medical strategy. As “plateau panic” drives patients toward faster answers, California Trim Clinic is urging patients not to confuse mouse data, forum chatter, or gray-market dosing assumptions with proven clinical care. The safer path starts with structured evaluation, Tirzepatide optimization, and next-phase conversations around medically supervised options like Retatrutide when appropriate.